story of the week
Association Between the Use of Incretin-Based Drugs and the Risk of Diabetic Retinopathy in Individuals With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies
Diabetes Obes Metab 2023 Nov 29;[EPub Ahead of Print], S Igweokpala, NO Sule, A Douros, OHY Yu, KB FilionFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.